{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:19:35Z","timestamp":1793650775195,"version":"4.5.1"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1007\/s12035-024-04115-6","type":"journal-article","created":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T04:01:35Z","timestamp":1712548895000},"page":"9110-9124","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["HAT and HDAC: Enzyme with Contradictory Action in Neurodegenerative Diseases"],"prefix":"10.1007","volume":"61","author":[{"given":"Richa","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaina Singh","family":"Rathore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hagera","family":"Dilnashin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priyanka Kumari","family":"Keshri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitesh Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Singh Ankit Satya","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walia","family":"Zahra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shekhar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0369-4699","authenticated-orcid":false,"given":"Surya Pratap","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,8]]},"reference":[{"key":"4115_CR1","doi-asserted-by":"publisher","unstructured":"Tora\u00f1o EG, Garc\u00eda MG, Fern\u00e1ndez-Morera JL, Ni\u00f1o-Garc\u00eda P, Fern\u00e1ndez AF (2016) The impact of external factors on the epigenome: in utero and over lifetime.\u00a0BioMed Res Int 2016. https:\/\/doi.org\/10.1155\/2016\/2568635","DOI":"10.1155\/2016\/2568635"},{"key":"4115_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.3389\/fncel.2015.0005","volume":"9","author":"J Landgrave-G\u00f3mez","year":"2015","unstructured":"Landgrave-G\u00f3mez J, Mercado-G\u00f3mez O, Guevara-Guzm\u00e1n R (2015) Epigenetic mechanisms in neurological and neurodegenerative diseases. Front Cell Neurosci 9:58. https:\/\/doi.org\/10.3389\/fncel.2015.0005","journal-title":"Front Cell Neurosci"},{"issue":"4","key":"4115_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1124\/mol.109.062174","volume":"77","author":"C Song","year":"2010","unstructured":"Song C, Kanthasamy A, Anantharam V, Sun F, Kanthasamy AG (2010) Environmental neurotoxic pesticide increases histone acetylation to promote apoptosis in dopaminergic neuronal cells: relevance to epigenetic mechanisms of neurodegeneration. Mol Pharmacol 77(4):621\u2013632. https:\/\/doi.org\/10.1124\/mol.109.062174","journal-title":"Mol Pharmacol"},{"key":"4115_CR4","doi-asserted-by":"publisher","unstructured":"Grova N, Schroeder H, Olivier JL, Turner JD (2019) Epigenetic and neurological impairments associated with early life exposure to persistent organic pollutants.\u00a0Int J Genom 2019. https:\/\/doi.org\/10.1155\/2019\/2085496","DOI":"10.1155\/2019\/2085496"},{"issue":"1","key":"4115_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.phrs.2010.01.011","volume":"62","author":"KC Dietz","year":"2010","unstructured":"Dietz KC, Casaccia P (2010) HDAC inhibitors and neurodegeneration: at the edge between protection and damage. Pharmacol Res 62(1):11\u201317. https:\/\/doi.org\/10.1016\/j.phrs.2010.01.011","journal-title":"Pharmacol Res"},{"issue":"2","key":"4115_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ije.2021.5","volume":"1","author":"S Swaroop","year":"2021","unstructured":"Swaroop S, Batabyal A, Bhattacharjee A (2021) HAT\/HDAC: The epigenetic regulators of inflammatory gene expression. Int J Epigen 1(2):1\u201313. https:\/\/doi.org\/10.3892\/ije.2021.5","journal-title":"Int J Epigen"},{"issue":"9","key":"4115_CR7","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s11064-013-1098-9","volume":"38","author":"MR Hasan","year":"2013","unstructured":"Hasan MR, Kim JH, Kim YJ, Kwon KJ, Shin CY, Kim HY, Han SH, Choi DH, Lee J (2013) Effect of HDAC inhibitors on neuroprotection and neurite outgrowth in primary rat cortical neurons following ischemic insult. Neurochem Res 38(9):1921\u20131934. https:\/\/doi.org\/10.1007\/s11064-013-1098-9","journal-title":"Neurochem Res"},{"issue":"4","key":"4115_CR8","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018713","volume":"6","author":"E Seto","year":"2014","unstructured":"Seto E, Yoshida M (2014) Erasers of histone acetylation: the histone deacetylase enzymes. Cold Spring Harb Perspect Biol 6(4):a018713. https:\/\/doi.org\/10.1101\/cshperspect.a018713","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4115_CR9","doi-asserted-by":"publisher","unstructured":"Delcuve GP, Khan DH, Davie JR (2013) Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors.\u00a0Epigenetics and Pathology: Exploring Connections between Genetic Mechanisms and Disease Expression. Apple Academic Press, 143\u2013171. https:\/\/doi.org\/10.1186\/1868-7083-4-5","DOI":"10.1186\/1868-7083-4-5"},{"issue":"22","key":"4115_CR10","doi-asserted-by":"publisher","first-page":"6789","DOI":"10.1073\/pnas.1501482112","volume":"112","author":"EB Keverne","year":"2015","unstructured":"Keverne EB, Pfaff DW, Tabansky I (2015) Epigenetic changes in the developing brain: effects on behavior. Proc Natl Acad Sci 112(22):6789\u20136795. https:\/\/doi.org\/10.1073\/pnas.1501482112","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"4115_CR11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1523\/JNEUROSCI.1649-20.2020","volume":"41","author":"P Mews","year":"2021","unstructured":"Mews P, Calipari ES, Day J, Lobo MK, Bredy T, Abel T (2021) From circuits to chromatin: the emerging role of epigenetics in mental health. J Neurosci 41(5):873\u2013882. https:\/\/doi.org\/10.1523\/JNEUROSCI.1649-20.2020","journal-title":"J Neurosci"},{"key":"4115_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12038-019-9974-3","volume":"45","author":"S Sikder","year":"2020","unstructured":"Sikder S, Kaypee S, Kundu TK (2020) Regulation of epigenetic state by non-histone chromatin proteins and transcription factors: Implications in disease. J Biosci 45:1\u201316","journal-title":"J Biosci"},{"issue":"3","key":"4115_CR13","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/j.bbagrm.2015.10.004","volume":"1859","author":"AA Kalashnikova","year":"2016","unstructured":"Kalashnikova AA, Rogge RA, Hansen JC (2016) Linker histone H1 and protein-protein interactions. Biochem Biophys Acta 1859(3):455\u2013461. https:\/\/doi.org\/10.1016\/j.bbagrm.2015.10.004","journal-title":"Biochem Biophys Acta"},{"key":"4115_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.852272","volume":"13","author":"Y Lin","year":"2022","unstructured":"Lin Y, Qiu T, Wei G, Que Y, Wang W, Kong Y, Xie T, Chen X (2022) Role of histone post-translational modifications in inflammatory diseases. Front Immunol 13:852272. https:\/\/doi.org\/10.3389\/fimmu.2022.852272","journal-title":"Front Immunol"},{"key":"4115_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12038-020-00099-2","volume":"45","author":"S Ramazi","year":"2020","unstructured":"Ramazi S, Allahverdi A, Zahiri J (2020) Evaluation of post-translational modifications in histone proteins: a review on histone modification defects in developmental and neurological disorders. J Biosci 45:1\u201329","journal-title":"J Biosci"},{"issue":"7620","key":"4115_CR16","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1038\/nature19947","volume":"537","author":"JW Harper","year":"2016","unstructured":"Harper JW, Bennett EJ (2016) Proteome complexity and the forces that drive proteome imbalance. Nature 537(7620):328\u2013338. https:\/\/doi.org\/10.1038\/nature19947","journal-title":"Nature"},{"key":"4115_CR17","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fncel.2013.00030","volume":"7","author":"SK Pirooznia","year":"2013","unstructured":"Pirooznia SK, Elefant F (2013) Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities. Front Cell Neurosci 7:30. https:\/\/doi.org\/10.3389\/fncel.2013.00030","journal-title":"Front Cell Neurosci"},{"key":"4115_CR18","doi-asserted-by":"publisher","unstructured":"Rathore AS, Birla H, Singh SS, Zahra W, Dilnashin H, Singh R, ..., Singh SP (2021) Epigenetic modulation in Parkinson\u2019s disease and potential treatment therapies.\u00a0Neurochem Res 46(7):1618\u20131626. https:\/\/doi.org\/10.1007\/s11064-021-03334-w","DOI":"10.1007\/s11064-021-03334-w"},{"key":"4115_CR19","doi-asserted-by":"publisher","unstructured":"Bowman GD, Poirier MG (2014) Post-translational modifications of histones that Tizabi, Y., Getachew, B., & Aschner, M. (2021). Novel pharmacotherapies in Parkinson\u2019s disease.\u00a0Neurotox Res 39(4):1381\u20131390. https:\/\/doi.org\/10.1007\/s12640-021-00375-5","DOI":"10.1007\/s12640-021-00375-5"},{"key":"4115_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12958-020-00637-5","volume":"18","author":"P Gujral","year":"2020","unstructured":"Gujral P, Mahajan V, Lissaman AC, Ponnampalam AP (2020) Histone acetylation and the role of histone deacetylases in normal cyclic endometrium. Reprod Biol Endocrinol 18:1\u201311. https:\/\/doi.org\/10.1186\/s12958-020-00637-5","journal-title":"Reprod Biol Endocrinol"},{"issue":"10","key":"4115_CR21","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.3390\/genes12101596","volume":"12","author":"V Cavalieri","year":"2021","unstructured":"Cavalieri V (2021) The expanding constellation of histone post-translational modifications in the epigenetic landscape. Genes 12(10):1596. https:\/\/doi.org\/10.3390\/genes12101596","journal-title":"Genes"},{"issue":"3","key":"4115_CR22","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/cr.2011.22","volume":"21","author":"AJ Bannister","year":"2011","unstructured":"Bannister AJ, Kouzarides T (2011) Regulation of chromatin by histone modifications. Cell Res 21(3):381\u2013395. https:\/\/doi.org\/10.1038\/cr.2011.22","journal-title":"Cell Res"},{"key":"4115_CR23","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1146\/annurev-biophys-070317-032847","volume":"48","author":"B Fierz","year":"2019","unstructured":"Fierz B, Poirier MG (2019) Biophysics of chromatin dynamics. Annu Rev Biophys 48:321\u2013345. https:\/\/doi.org\/10.1146\/annurev-biophys-070317-032847","journal-title":"Annu Rev Biophys"},{"issue":"9","key":"4115_CR24","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1111\/febs.13047","volume":"282","author":"AF Kebede","year":"2015","unstructured":"Kebede AF, Schneider R, Daujat S (2015) Novel types and sites of histone modifications emerge as players in the transcriptional regulation contest. FEBS J 282(9):1658\u20131674. https:\/\/doi.org\/10.1111\/febs.13047","journal-title":"FEBS J"},{"key":"4115_CR25","doi-asserted-by":"publisher","unstructured":"Di Cerbo V, Mohn F, Ryan DP, Montellier E, Kacem S, Tropberger P, ..., Schneider R (2014) Acetylation of histone H3 at lysine 64 regulates nucleosome dynamics and facilitates transcription.\u00a0elife 3:e01632. https:\/\/doi.org\/10.7554\/eLife.01632","DOI":"10.7554\/eLife.01632"},{"key":"4115_CR26","doi-asserted-by":"publisher","unstructured":"Miller JL, Grant PA (2012) The role of DNA methylation and histone modifications in transcriptional regulation in humans.\u00a0Epigene: Dev Dis 289\u201331. https:\/\/doi.org\/10.1007\/978-94-007-4525-4_13","DOI":"10.1007\/978-94-007-4525-4_13"},{"key":"4115_CR27","doi-asserted-by":"publisher","unstructured":"Tropberger P, Pott S, Keller C, Kamieniarz-Gdula K, Caron M, Richter F, ..., Schneider R (2013) Regulation of transcription through acetylation of H3K122 on the lateral surface of the histone octamer.\u00a0Cell 152(4):859\u2013872. https:\/\/doi.org\/10.1016\/j.cell.2013.01.032","DOI":"10.1016\/j.cell.2013.01.032"},{"issue":"2","key":"4115_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4161\/epi.5.2.11075","volume":"5","author":"P Tropberger","year":"2010","unstructured":"Tropberger P, Schneider R (2010) Going global: novel histone modifications in the globular domain of H3. Epigenetics 5(2):112\u2013117. https:\/\/doi.org\/10.4161\/epi.5.2.11075","journal-title":"Epigenetics"},{"key":"4115_CR29","doi-asserted-by":"publisher","unstructured":"Chatterjee N, North JA, Dechassa ML, Manohar M, Prasad R, Luger K, ..., Bartholomew B (2015) Histone acetylation near the nucleosome dyad axis enhances nucleosome disassembly by RSC and SWI\/SNF.\u00a0Mol Cell Biol 35(23):4083\u20134092. https:\/\/doi.org\/10.1128\/MCB.00441-15","DOI":"10.1128\/MCB.00441-15"},{"key":"4115_CR30","doi-asserted-by":"publisher","unstructured":"Wang Y, Miao X, Liu Y, Li F, Liu Q, Sun J, Cai L (2014) Dysregulation of histone acetyltransferases and deacetylases in cardiovascular diseases.\u00a0Oxid Med Cell Longev 2014. https:\/\/doi.org\/10.1155\/2014\/641979","DOI":"10.1155\/2014\/641979"},{"issue":"7","key":"4115_CR31","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a018762","volume":"6","author":"R Marmorstein","year":"2014","unstructured":"Marmorstein R, Zhou MM (2014) Writers and readers of histone acetylation: structure, mechanism, and inhibition. Cold Spring Harb Perspect Biol 6(7):a018762. https:\/\/doi.org\/10.1101\/cshperspect.a018762","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"4115_CR32","doi-asserted-by":"publisher","unstructured":"Camilo V, Jer\u00f3nimo C (2020) Present and future perspectives for targeting histone modifications in therapy. In\u00a0Histone Modifications in Therapy\u00a0(pp 415\u2013457). Academic Press 2.\u00a0https:\/\/doi.org\/10.1016\/B978-0-12-816422-8.00018-0","DOI":"10.1016\/B978-0-12-816422-8.00018-0"},{"key":"4115_CR33","doi-asserted-by":"publisher","unstructured":"Ma Y, Li Q, Li A, Wei Y, Long P, Jiang X, ..., Schwartz RJ (2017) The CSRP2BP histone acetyltransferase drives smooth muscle gene expression.\u00a0Nucl Acids Res 45(6):3046\u20133058. https:\/\/doi.org\/10.1093\/nar\/gkw1227","DOI":"10.1093\/nar\/gkw1227"},{"key":"4115_CR34","unstructured":"Al Aboud NM, Tupper C, Jialal I (2018) Genetics, epigenetic mechanism. StatPearls Publishing, In StatPearls"},{"issue":"3","key":"4115_CR35","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s00441-014-1835-7","volume":"356","author":"BN Sheikh","year":"2014","unstructured":"Sheikh BN (2014) Crafting the brain\u2013role of histone acetyltransferases in neural development and disease. Cell Tissue Res 356(3):553\u2013573. https:\/\/doi.org\/10.1007\/s00441-014-1835-7","journal-title":"Cell Tissue Res"},{"issue":"11","key":"4115_CR36","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1002\/pro.3496","volume":"27","author":"ER Weikum","year":"2018","unstructured":"Weikum ER, Liu X, Ortlund EA (2018) The nuclear receptor superfamily: a structural perspective. Protein Sci 27(11):1876\u20131892. https:\/\/doi.org\/10.1002\/pro.3496","journal-title":"Protein Sci"},{"issue":"4","key":"4115_CR37","doi-asserted-by":"publisher","first-page":"247","DOI":"10.18632\/aging.100453","volume":"4","author":"DC Bedford","year":"2012","unstructured":"Bedford DC, Brindle PK (2012) Is histone acetylation the most important physiological function for CBP and p300? Aging 4(4):247. https:\/\/doi.org\/10.18632\/aging.100453","journal-title":"Aging"},{"key":"4115_CR38","doi-asserted-by":"publisher","unstructured":"Chakraborty R, Ostriker AC, Xie Y, Dave JM, Gamez-Mendez A, Chatterjee P, ..., Martin KA (2022) Histone acetyltransferases p300 and CBP coordinate distinct chromatin remodeling programs in vascular smooth muscle plasticity.\u00a0Circulation 145(23):1720\u20131737. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.121.057599","DOI":"10.1161\/CIRCULATIONAHA.121.057599"},{"issue":"8","key":"4115_CR39","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1016\/j.molcel.2021.01.031","volume":"81","author":"L Ma","year":"2021","unstructured":"Ma L, Gao Z, Wu J, Zhong B, Xie Y, Huang W, Lin Y (2021) Co-condensation between transcription factor and coactivator p300 modulates transcriptional bursting kinetics. Mol Cell 81(8):1682\u20131697. https:\/\/doi.org\/10.1016\/j.molcel.2021.01.031","journal-title":"Mol Cell"},{"issue":"7","key":"4115_CR40","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.1600584","volume":"2","author":"S Pal","year":"2016","unstructured":"Pal S, Tyler JK (2016) Epigenetics and aging. Sci Adv 2(7):e1600584. https:\/\/doi.org\/10.1126\/sciadv.1600584","journal-title":"Sci Adv"},{"key":"4115_CR41","doi-asserted-by":"publisher","unstructured":"Korzus E (2017) Rubinstein-Taybi syndrome and epigenetic alterations.\u00a0Neuroepigenom Aging Dis 39\u201362. https:\/\/doi.org\/10.1007\/978-3-319-53889-1_3","DOI":"10.1007\/978-3-319-53889-1_3"},{"issue":"5","key":"4115_CR42","doi-asserted-by":"publisher","first-page":"556","DOI":"10.3390\/genes11050556","volume":"11","author":"G Milazzo","year":"2020","unstructured":"Milazzo G, Mercatelli D, Di Muzio G, Triboli L, De Rosa P, Perini G, Giorgi FM (2020) Histone deacetylases (HDACs): evolution, specificity, role in transcriptional complexes, and pharmacological actionability. Genes 11(5):556. https:\/\/doi.org\/10.3390\/genes11050556","journal-title":"Genes"},{"issue":"1","key":"4115_CR43","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s42003-018-0214-4","volume":"1","author":"M B\u00fcrger","year":"2018","unstructured":"B\u00fcrger M, Chory J (2018) Structural and chemical biology of deacetylases for carbohydrates, proteins, small molecules and histones. Commun Biol 1(1):217. https:\/\/doi.org\/10.1038\/s42003-018-0214-4","journal-title":"Commun Biol"},{"issue":"1","key":"4115_CR44","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/radiation2010011","volume":"2","author":"J Antrobus","year":"2022","unstructured":"Antrobus J, Parsons JL (2022) Histone deacetylases and their potential as targets to enhance tumour radiosensitisation. Radiation 2(1):149\u2013167. https:\/\/doi.org\/10.3390\/radiation2010011","journal-title":"Radiation"},{"key":"4115_CR45","doi-asserted-by":"publisher","unstructured":"Lobera M, Madauss KP, Pohlhaus DT, Wright QG, Trocha M, Schmidt DR, ..., Nolan MA (2013) Selective class IIa histone deacetylase inhibition via a nonchelating zinc-binding group.\u00a0Nat Chem Biol 9(5), 319\u2013325. https:\/\/doi.org\/10.1038\/nchembio.1223","DOI":"10.1038\/nchembio.1223"},{"key":"4115_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1868-7083-4-5","volume":"4","author":"GP Delcuve","year":"2012","unstructured":"Delcuve GP, Khan DH, Davie JR (2012) Roles of histone deacetylases in epigenetic regulation: emerging paradigms from studies with inhibitors. Clin Epigenet 4:1\u201313. https:\/\/doi.org\/10.1186\/1868-7083-4-5","journal-title":"Clin Epigenet"},{"issue":"2","key":"4115_CR47","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/s12276-020-0382-4","volume":"52","author":"SY Park","year":"2020","unstructured":"Park SY, Kim JS (2020) A short guide to histone deacetylases including recent progress on class II enzymes. Exp Mol Med 52(2):204\u2013212. https:\/\/doi.org\/10.1038\/s12276-020-0382-4","journal-title":"Exp Mol Med"},{"issue":"1","key":"4115_CR48","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/acel.12538","volume":"16","author":"A Ansari","year":"2017","unstructured":"Ansari A, Rahman MS, Saha SK, Saikot FK, Deep A, Kim KH (2017) Function of the SIRT 3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease. Aging Cell 16(1):4\u201316. https:\/\/doi.org\/10.1111\/acel.12538","journal-title":"Aging Cell"},{"issue":"32","key":"4115_CR49","doi-asserted-by":"publisher","first-page":"11021","DOI":"10.1074\/jbc.REV120.011438","volume":"295","author":"MA Klein","year":"2020","unstructured":"Klein MA, Denu JM (2020) Biological and catalytic functions of sirtuin 6 as targets for small-molecule modulators. J Biol Chem 295(32):11021\u201311041. https:\/\/doi.org\/10.1074\/jbc.REV120.011438","journal-title":"J Biol Chem"},{"issue":"10","key":"4115_CR50","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1111\/febs.15895","volume":"289","author":"Y N\u00fa\u00f1ez-\u00c1lvarez","year":"2022","unstructured":"N\u00fa\u00f1ez-\u00c1lvarez Y, Suelves M (2022) HDAC11: a multifaceted histone deacetylase with proficient fatty deacylase activity and its roles in physiological processes. FEBS J 289(10):2771\u20132792. https:\/\/doi.org\/10.1111\/febs.15895","journal-title":"FEBS J"},{"issue":"4","key":"4115_CR51","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.12989","volume":"21","author":"AN Nutsford","year":"2019","unstructured":"Nutsford AN, Galvin HD, Ahmed F, Husain M (2019) The Class IV human deacetylase, HDAC11, exhibits anti-influenza A virus properties via its involvement in host innate antiviral response. Cell Microbiol 21(4):e12989. https:\/\/doi.org\/10.1111\/cmi.12989","journal-title":"Cell Microbiol"},{"issue":"11","key":"4115_CR52","doi-asserted-by":"publisher","first-page":"792","DOI":"10.3390\/metabo11110792","volume":"11","author":"J King","year":"2021","unstructured":"King J, Patel M, Chandrasekaran S (2021) Metabolism, HDACs, and HDAC inhibitors: a systems biology perspective. Metabolites 11(11):792. https:\/\/doi.org\/10.3390\/metabo11110792","journal-title":"Metabolites"},{"issue":"1","key":"4115_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener 14(1):1\u201318. https:\/\/doi.org\/10.1186\/s13024-019-0333-5","journal-title":"Mol Neurodegener"},{"issue":"1","key":"4115_CR54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.31083\/j.jin2101028","volume":"21","author":"LA Manwell","year":"2022","unstructured":"Manwell LA, Tadros M, Ciccarelli TM, Eikelboom R (2022) Digital dementia in the internet generation: excessive screen time during brain development will increase the risk of Alzheimer\u2019s disease and related dementias in adulthood. J Integr Neurosci 21(1):28. https:\/\/doi.org\/10.31083\/j.jin2101028","journal-title":"J Integr Neurosci"},{"issue":"1","key":"4115_CR55","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3390\/ijms21010209","volume":"21","author":"T Zhang","year":"2019","unstructured":"Zhang T, Chen D, Lee TH (2019) Phosphorylation signaling in APP processing in Alzheimer\u2019s disease. Int J Mol Sci 21(1):209. https:\/\/doi.org\/10.3390\/ijms21010209","journal-title":"Int J Mol Sci"},{"issue":"8","key":"4115_CR56","doi-asserted-by":"publisher","first-page":"740","DOI":"10.2174\/1570159X18666200128125641","volume":"18","author":"VK Sharma","year":"2020","unstructured":"Sharma VK, Mehta V, Singh TG (2020) Alzheimer\u2019s disorder: epigenetic connection and associated risk factors. Curr Neuropharmacol 18(8):740\u2013753. https:\/\/doi.org\/10.2174\/1570159X18666200128125641","journal-title":"Curr Neuropharmacol"},{"key":"4115_CR57","unstructured":"Creighton S (2019) Amelioration of memory deficits in a transgenic mouse model of Alzheimer\u2019s disease by manipulation of the histone acetyltransferase p300\/CBP associated factor (PCAF)\u00a0(Doctoral dissertation, University of Guelph).\u00a0http:\/\/hdl.handle.net\/10214\/17368"},{"issue":"8","key":"4115_CR58","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.tibs.2016.05.008","volume":"41","author":"S Peleg","year":"2016","unstructured":"Peleg S, Feller C, Ladurner AG, Imhof A (2016) The metabolic impact on histone acetylation and transcription in ageing. Trends Biochem Sci 41(8):700\u2013711. https:\/\/doi.org\/10.1016\/j.tibs.2016.05.008","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"4115_CR59","doi-asserted-by":"publisher","first-page":"132","DOI":"10.14336\/AD.2020.0329","volume":"12","author":"Y Li","year":"2021","unstructured":"Li Y, Huang H, Zhu M, Bai H, Huang X (2021) Roles of the MYST family in the pathogenesis of Alzheimer\u2019s disease via histone or non-histone acetylation. Aging Di 12(1):132\u2013142. https:\/\/doi.org\/10.14336\/AD.2020.0329","journal-title":"Aging Di"},{"key":"4115_CR60","doi-asserted-by":"publisher","unstructured":"Nativio R, Lan Y, Donahue G, Sidoli S, Berson A, Srinivasan AR, ..., Berger SL (2020) An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer\u2019s disease.\u00a0Nat Genet 52(10):1024\u20131035. https:\/\/doi.org\/10.1038\/s41588-020-0696-0","DOI":"10.1038\/s41588-020-0696-0"},{"issue":"11","key":"4115_CR61","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41593-018-0253-7","volume":"21","author":"SJ Marzi","year":"2018","unstructured":"Marzi SJ, Leung SK, Ribarska T, Hannon E, Smith AR, Pishva E, Poschmann J, Moore K et al (2018) A histone acetylome-wide association study of Alzheimer\u2019s disease identifies disease-associated H3K27ac differences in the entorhinal cortex. Nat Neurosci 21(11):1618\u20131627. https:\/\/doi.org\/10.1038\/s41593-018-0253-7","journal-title":"Nat Neurosci"},{"issue":"2","key":"4115_CR62","doi-asserted-by":"publisher","first-page":"347","DOI":"10.3390\/genes14020347","volume":"14","author":"DA Santana","year":"2023","unstructured":"Santana DA, Smith MAC, Chen ES (2023) Histone modifications in Alzheimer\u2019s disease. Genes 14(2):347. https:\/\/doi.org\/10.3390\/genes14020347","journal-title":"Genes"},{"issue":"8","key":"4115_CR63","doi-asserted-by":"publisher","first-page":"752","DOI":"10.2174\/1567205012666150710114256","volume":"12","author":"B Plagg","year":"2015","unstructured":"Plagg B, Ehrlich D, Kniewallner KM, Marksteiner J, Humpel C (2015) Increased acetylation of histone H4 at lysine 12 (H4K12) in monocytes of transgenic Alzheimer\u2019s mice and in human patients. Curr Alzheimer Res 12(8):752\u2013760. https:\/\/doi.org\/10.2174\/1567205012666150710114256","journal-title":"Curr Alzheimer Res"},{"issue":"Suppl 1","key":"4115_CR64","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4137\/JEN.S39888","volume":"10","author":"G Vierci","year":"2016","unstructured":"Vierci G, Pannunzio B, Bornia N, Rossi FM (2016) H3 and H4 lysine acetylation correlates with developmental and experimentally induced adult experience-dependent plasticity in the mouse visual cortex. J Exp Neurosci 10(Suppl 1):49\u201364. https:\/\/doi.org\/10.4137\/JEN.S39888","journal-title":"J Exp Neurosci"},{"key":"4115_CR65","doi-asserted-by":"publisher","unstructured":"Hugais MM, Cobos SN, Bennett SA, Paredes J, Foran G, Torrente MP (2021) Changes in histone H3 Acetylation on lysine 9 accompany A\u03b2 1\u201340 overexpression in an Alzheimer\u2019s disease Yeast Model.\u00a0Micropubl Biol 2021. https:\/\/doi.org\/10.17912\/micropub.biology.000492","DOI":"10.17912\/micropub.biology.000492"},{"issue":"1","key":"4115_CR66","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/s41392-022-01078-9","volume":"7","author":"J Park","year":"2022","unstructured":"Park J, Lee K, Kim K, Yi SJ (2022) The role of histone modifications: from neurodevelopment to neurodiseases. Signal Transduct Target Ther 7(1):217. https:\/\/doi.org\/10.1038\/s41392-022-01078-9","journal-title":"Signal Transduct Target Ther"},{"issue":"28","key":"4115_CR67","doi-asserted-by":"publisher","first-page":"5105","DOI":"10.2174\/1381612811319280009","volume":"19","author":"EB Fessler","year":"2013","unstructured":"Fessler EB, Chibane FL, Wang Z, Chuang DM (2013) Potential roles of HDAC inhibitors in mitigating ischemia-induced brain damage and facilitating endogenous regeneration and recovery. Curr Pharm Des 19(28):5105\u20135120. https:\/\/doi.org\/10.2174\/1381612811319280009","journal-title":"Curr Pharm Des"},{"issue":"24","key":"4115_CR68","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.1021\/acschemneuro.0c00696","volume":"11","author":"KY Yeong","year":"2020","unstructured":"Yeong KY, Berdigaliyev N, Chang Y (2020) Sirtuins and their implications in neurodegenerative diseases from a drug discovery perspective. ACS Chem Neurosci 11(24):4073\u20134091. https:\/\/doi.org\/10.1021\/acschemneuro.0c00696","journal-title":"ACS Chem Neurosci"},{"issue":"9","key":"4115_CR69","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1002\/embj.201387637","volume":"33","author":"A Fischer","year":"2014","unstructured":"Fischer A (2014) Epigenetic memory: the Lamarckian brain. EMBO J 33(9):945\u2013967. https:\/\/doi.org\/10.1002\/embj.201387637","journal-title":"EMBO J"},{"key":"4115_CR70","doi-asserted-by":"publisher","unstructured":"Yamakawa H, Cheng J, Penney J, Gao F, Rueda R, Wang J, ..., Tsai LH (2017) The transcription factor Sp3 cooperates with HDAC2 to regulate synaptic function and plasticity in neurons.\u00a0Cell Rep 20(6):1319\u20131334. https:\/\/doi.org\/10.1016\/j.celrep.2017.07.044","DOI":"10.1016\/j.celrep.2017.07.044"},{"issue":"10","key":"4115_CR71","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1093\/jnen\/nly073","volume":"77","author":"M Ziemka-Nalecz","year":"2018","unstructured":"Ziemka-Nalecz M, Jaworska J, Sypecka J, Zalewska T (2018) Histone deacetylase inhibitors: a therapeutic key in neurological disorders? J Neuropathol Exp Neurol 77(10):855\u2013870. https:\/\/doi.org\/10.1093\/jnen\/nly073","journal-title":"J Neuropathol Exp Neurol"},{"key":"4115_CR72","doi-asserted-by":"publisher","unstructured":"Hanson JE, La H, Plise E, Chen YH, Ding X, Hanania T, ..., Zhou Q (2013) SAHA enhances synaptic function and plasticity in vitro but has limited brain availability in vivo and does not impact cognition.\u00a0PLoS One 8(7):e69964. https:\/\/doi.org\/10.1371\/journal.pone.0069964","DOI":"10.1371\/journal.pone.0069964"},{"issue":"2","key":"4115_CR73","doi-asserted-by":"publisher","first-page":"171","DOI":"10.4103\/mgmj.mgmj_90_20","volume":"8","author":"CE Okechukwu","year":"2021","unstructured":"Okechukwu CE (2021) Deciphering and manipulating the epigenome for the treatment of Parkinson\u2019s and Alzheimer\u2019s disease. MGM J Med Sci 8(2):171","journal-title":"MGM J Med Sci"},{"key":"4115_CR74","doi-asserted-by":"publisher","unstructured":"Xuan AG, Pan XB, Wei P, Ji WD, Zhang WJ, Liu JH, ..., Long DH (2015) Valproic acid alleviates memory deficits and attenuates amyloid-\u03b2 deposition in transgenic mouse model of Alzheimer\u2019s disease.\u00a0Mol Neurobiol 51:300\u2013312. https:\/\/doi.org\/10.1007\/s12035-014-8751-4","DOI":"10.1007\/s12035-014-8751-4"},{"key":"4115_CR75","doi-asserted-by":"crossref","unstructured":"Choong CJ, Sasaki T, Hayakawa H, Yasuda T, Baba K, Hirata Y, ..., Mochizuki H (2016) A novel histone deacetylase 1 and 2 isoform-specific inhibitor alleviates experimental Parkinson's disease.\u00a0Neurobiol Aging 37:103\u2013116","DOI":"10.1016\/j.neurobiolaging.2015.10.001"},{"issue":"5","key":"4115_CR76","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1073\/pnas.0510341103","volume":"103","author":"MV Simonini","year":"2006","unstructured":"Simonini MV, Camargo LM, Dong E, Maloku E, Veldic M, Costa E, Guidotti A (2006) The benzamide MS-275 is a potent, long-lasting brain region-selective inhibitor of histone deacetylases. Proc Natl Acad Sci 103(5):1587\u20131592. https:\/\/doi.org\/10.1073\/pnas.0510341103","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"4115_CR77","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1097\/NEN.0b013e318283114a","volume":"72","author":"ZY Zhang","year":"2013","unstructured":"Zhang ZY, Schluesener HJ (2013) Oral administration of histone deacetylase inhibitor MS-275 ameliorates neuroinflammation and cerebral amyloidosis and improves behavior in a mouse model. J Neuropathol Exp Neurol 72(3):178\u2013185. https:\/\/doi.org\/10.1097\/NEN.0b013e318283114a","journal-title":"J Neuropathol Exp Neurol"},{"issue":"1","key":"4115_CR78","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13054","volume":"19","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Shen Q, Wu X, Zhang D, Xing D (2020) Activation of PKA\/SIRT1 signaling pathway by photobiomodulation therapy reduces A\u03b2 levels in Alzheimer\u2019s disease models. Aging Cell 19(1):e13054. https:\/\/doi.org\/10.1111\/acel.13054","journal-title":"Aging Cell"},{"key":"4115_CR79","doi-asserted-by":"publisher","unstructured":"Su Q, Li T, He PF, Lu XC, Yu Q, Gao QC, ..., Qi JS (2021) Trichostatin A ameliorates Alzheimer\u2019s disease-related pathology and cognitive deficits by increasing albumin expression and A\u03b2 clearance in APP\/PS1 mice.\u00a0Alzheimer's Res Ther 13(1):1\u201315. https:\/\/doi.org\/10.1186\/s13195-020-00746-8","DOI":"10.1186\/s13195-020-00746-8"},{"issue":"1","key":"4115_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0085570","volume":"9","author":"J Meng","year":"2014","unstructured":"Meng J, Li Y, Camarillo C, Yao Y, Zhang Y, Xu C, Jiang L (2014) The anti-tumor histone deacetylase inhibitor SAHA and the natural flavonoid curcumin exhibit synergistic neuroprotection against amyloid-beta toxicity. PLoS ONE 9(1):e85570. https:\/\/doi.org\/10.1371\/journal.pone.0085570","journal-title":"PLoS ONE"},{"issue":"17","key":"4115_CR81","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.3390\/ijms20174283","volume":"20","author":"H Jeong","year":"2019","unstructured":"Jeong H, Shin S, Lee JS, Lee SH, Baik JH, Lim S, Kim YK (2019) Pan-HDAC inhibitors promote tau aggregation by increasing the level of acetylated tau. Int J Mol Sci 20(17):4283. https:\/\/doi.org\/10.3390\/ijms20174283","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4115_CR82","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13024-021-00489-6","volume":"16","author":"A Iatrou","year":"2021","unstructured":"Iatrou A, Clark EM, Wang Y (2021) Nuclear dynamics and stress responses in Alzheimer\u2019s disease. Mol Neurodegener 16(1):65. https:\/\/doi.org\/10.1186\/s13024-021-00489-6","journal-title":"Mol Neurodegener"},{"key":"4115_CR83","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fncel.2015.00226","volume":"9","author":"X Lu","year":"2015","unstructured":"Lu X, Wang L, Yu C, Yu D, Yu G (2015) Histone acetylation modifiers in the pathogenesis of Alzheimer\u2019s disease. Front Cell Neurosci 9:226. https:\/\/doi.org\/10.3389\/fncel.2015.00226","journal-title":"Front Cell Neurosci"},{"issue":"5","key":"4115_CR84","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1002\/hipo.20883","volume":"22","author":"A Ricobaraza","year":"2012","unstructured":"Ricobaraza A, Cuadrado-Tejedor M, Marco S, P\u00e9rez-Ota\u00f1o I, Garc\u00eda-Osta A (2012) Phenylbutyrate rescues dendritic spine loss associated with memory deficits in a mouse model of Alzheimer disease. Hippocampus 22(5):1040\u20131050. https:\/\/doi.org\/10.1002\/hipo.20883","journal-title":"Hippocampus"},{"key":"4115_CR85","doi-asserted-by":"publisher","unstructured":"Janczura KJ, Volmar CH, Sartor GC, Rao SJ, Ricciardi NR, Lambert G, ..., Wahlestedt C (2018) Inhibition of HDAC3 reverses Alzheimer\u2019s disease-related pathologies in vitro and in the 3xTg-AD mouse model.\u00a0Proc Nat Acad Sci 115(47):E11148-E11157. https:\/\/doi.org\/10.1073\/pnas.1805436115","DOI":"10.1073\/pnas.1805436115"},{"key":"4115_CR86","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s40035-017-0089-1","volume":"6","author":"SS Yang","year":"2017","unstructured":"Yang SS, Zhang R, Wang G, Zhang YF (2017) The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer\u2019s disease. Transl Neurodegener 6:19. https:\/\/doi.org\/10.1186\/s40035-017-0089-1","journal-title":"Transl Neurodegener"},{"issue":"5","key":"4115_CR87","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1111\/acel.12642","volume":"16","author":"X Zhu","year":"2017","unstructured":"Zhu X, Wang S, Yu L, Jin J, Ye X, Liu Y, Xu Y (2017) HDAC 3 negatively regulates spatial memory in a mouse model of Alzheimer\u2019s disease. Aging Cell 16(5):1073\u20131082. https:\/\/doi.org\/10.1111\/acel.12642","journal-title":"Aging Cell"},{"issue":"8","key":"4115_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042983","volume":"7","author":"C Kim","year":"2012","unstructured":"Kim C, Choi H, Jung ES, Lee W, Oh S, Jeon NL, Mook-Jung I (2012) HDAC6 inhibitor blocks amyloid beta-induced impairment of mitochondrial transport in hippocampal neurons. PLoS ONE 7(8):e42983. https:\/\/doi.org\/10.1371\/journal.pone.0042983","journal-title":"PLoS ONE"},{"issue":"11","key":"4115_CR89","doi-asserted-by":"publisher","first-page":"2484","DOI":"10.1016\/j.bbadis.2015.08.012","volume":"1852","author":"P Guedes-Dias","year":"2015","unstructured":"Guedes-Dias P, de Proen\u00e7a J, Soares TR, Leit\u00e3o-Rocha A, Pinho BR, Duchen MR, Oliveira JM (2015) HDAC6 inhibition induces mitochondrial fusion, autophagic flux and reduces diffuse mutant huntingtin in striatal neurons. Biochim Biophys Acta Mol Basis Dis 1852(11):2484\u20132493. https:\/\/doi.org\/10.1016\/j.bbadis.2015.08.012","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"4115_CR90","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.neuropharm.2014.01.038","volume":"80","author":"A Fischer","year":"2014","unstructured":"Fischer A (2014) Targeting histone-modifications in Alzheimer\u2019s disease. What is the evidence that this is a promising therapeutic avenue? Neuropharmacology 80:95\u2013102. https:\/\/doi.org\/10.1016\/j.neuropharm.2014.01.038","journal-title":"Neuropharmacology"},{"key":"4115_CR91","doi-asserted-by":"publisher","unstructured":"Singh R, Zahra W, Singh SS, Birla H, Rathore AS, Keshri PK, ..., Singh SP (2023) Oleuropein confers neuroprotection against rotenone-induced model of Parkinson\u2019s disease via BDNF\/CREB\/Akt pathway.\u00a0Sci Rep 13(1):2452. https:\/\/doi.org\/10.1038\/s41598-023-29287-4","DOI":"10.1038\/s41598-023-29287-4"},{"issue":"19","key":"4115_CR92","doi-asserted-by":"publisher","first-page":"7182","DOI":"10.3390\/ijms21197182","volume":"21","author":"R Wang","year":"2020","unstructured":"Wang R, Sun H, Wang G, Ren H (2020) Imbalance of lysine acetylation contributes to the pathogenesis of Parkinson\u2019s disease. Int J Mol Sci 21(19):7182. https:\/\/doi.org\/10.3390\/ijms21197182","journal-title":"Int J Mol Sci"},{"key":"4115_CR93","doi-asserted-by":"publisher","unstructured":"Zhou T, Lin D, Chen Y, Peng S, Jing X, Lei M, ..., Liang Y (2019) \u03b1-synuclein accumulation in SH-SY5Y cell impairs autophagy in microglia by exosomes overloading miR-19a-3p.\u00a0Epigenomics 11(15):1661\u20131677. https:\/\/doi.org\/10.2217\/epi-2019-0222","DOI":"10.2217\/epi-2019-0222"},{"key":"4115_CR94","doi-asserted-by":"publisher","unstructured":"Mizuno H, Fujikake N, Wada K, Nagai Y (2011) \u03b1-Synuclein transgenic Drosophila as a model of Parkinson's disease and related synucleinopathies.\u00a0Parkinson\u2019s Dis 2011. https:\/\/doi.org\/10.4061\/2011\/212706","DOI":"10.4061\/2011\/212706"},{"issue":"7","key":"4115_CR95","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1002\/mds.28066","volume":"35","author":"N Omer","year":"2020","unstructured":"Omer N, Giladi N, Gurevich T, Bar-Shira A, Gana-Weisz M, Goldstein O, Kestenbaum M, Cedarbaum JM, Orr-Urtreger A, Mirelman A, Thaler A (2020) A possible modifying effect of the G2019S mutation in the LRRK2 gene on GBA Parkinson\u2019s disease. Mov Disord 35(7):1249\u20131253. https:\/\/doi.org\/10.1002\/mds.28066","journal-title":"Mov Disord"},{"issue":"6","key":"4115_CR96","doi-asserted-by":"publisher","first-page":"975","DOI":"10.4103\/1673-5374.250575","volume":"14","author":"SM Yakhine-Diop","year":"2019","unstructured":"Yakhine-Diop SM, Mart\u00ednez-Chac\u00f3n G, Uribe-Carretero E, Niso-Santano M, Gonz\u00e1lez-Polo RA, Fuentes JM (2019) The paradigm of protein acetylation in Parkinson\u2019s disease. Neural Regen Res 14(6):975. https:\/\/doi.org\/10.4103\/1673-5374.250575","journal-title":"Neural Regen Res"},{"key":"4115_CR97","doi-asserted-by":"publisher","unstructured":"Toker L, Tran GT, Sundaresan J, Tysnes OB, Alves G, Haugarvoll K, ..., Tzoulis C (2021)\u00a0 Genome-wide histone acetylation analysis reveals altered transcriptional regulation in the Parkinson\u2019s disease brain.\u00a0Mol Neurodegener 16(1):1\u201320. https:\/\/doi.org\/10.1186\/s13024-021-00450-7","DOI":"10.1186\/s13024-021-00450-7"},{"issue":"17","key":"4115_CR98","doi-asserted-by":"publisher","first-page":"14941","DOI":"10.1074\/jbc.M110.211029","volume":"286","author":"W Zhou","year":"2011","unstructured":"Zhou W, Bercury K, Cummiskey J, Luong N, Lebin J, Freed CR (2011) Phenylbutyrate up-regulates the DJ-1 protein and protects neurons in cell culture and in animal models of Parkinson disease. J Biol Chem 286(17):14941\u201314951. https:\/\/doi.org\/10.1074\/jbc.M110.211029","journal-title":"J Biol Chem"},{"issue":"9","key":"4115_CR99","doi-asserted-by":"publisher","first-page":"6970","DOI":"10.1007\/s12035-016-0199-2","volume":"54","author":"Q Wu","year":"2017","unstructured":"Wu Q, Yang X, Zhang L, Zhang Y, Feng L (2017) Nuclear accumulation of histone deacetylase 4 (HDAC4) exerts neurotoxicity in models of Parkinson\u2019s disease. Mol Neurobiol 54(9):6970\u20136983. https:\/\/doi.org\/10.1007\/s12035-016-0199-2","journal-title":"Mol Neurobiol"},{"key":"4115_CR100","doi-asserted-by":"publisher","unstructured":"Wang L, Liu L, Han C, Jiang H, Ma K, Guo S, ..., Wang T (2023) Histone deacetylase 4 inhibition reduces rotenone-induced alpha-synuclein accumulation via autophagy in SH-SY5Y cells.\u00a0Brain Sci 13(4):670. https:\/\/doi.org\/10.3390\/brainsci13040670","DOI":"10.3390\/brainsci13040670"},{"key":"4115_CR101","doi-asserted-by":"publisher","unstructured":"Mazzocchi M, Wyatt SL, Mercatelli D, Morari M, Morales-Prieto N, Collins LM, ..., O\u2019Keeffe GW (2019) Gene co-expression analysis identifies histone deacetylase 5 and 9 expression in midbrain dopamine neurons and as regulators of neurite growth via bone morphogenetic protein signaling.\u00a0Front Cell Dev Biol 7:191. https:\/\/doi.org\/10.3389\/fcell.2019.00191","DOI":"10.3389\/fcell.2019.00191"},{"key":"4115_CR102","doi-asserted-by":"publisher","unstructured":"Mazzocchi M, Collins LM, Sullivan AM, O'Keeffe GW (2020) The class II histone deacetylases as therapeutic targets for Parkinson\u2019s disease.\u00a0Neuronal Signal 4(2). https:\/\/doi.org\/10.1042\/NS20200001","DOI":"10.1042\/NS20200001"},{"issue":"7","key":"4115_CR103","doi-asserted-by":"publisher","first-page":"3531","DOI":"10.1074\/jbc.M115.675488","volume":"291","author":"G Park","year":"2016","unstructured":"Park G, Tan J, Garcia G, Kang Y, Salvesen G, Zhang Z (2016) Regulation of histone acetylation by autophagy in Parkinson disease. J Biol Chem 291(7):3531\u20133540. https:\/\/doi.org\/10.1074\/jbc.M115.675488","journal-title":"J Biol Chem"},{"issue":"6","key":"4115_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0038113","volume":"7","author":"A Roy","year":"2012","unstructured":"Roy A, Ghosh A, Jana A, Liu X, Brahmachari S, Gendelman HE, Pahan K (2012) Sodium phenylbutyrate controls neuroinflammatory and antioxidant activities and protects dopaminergic neurons in mouse models of Parkinson\u2019s disease. PLoS ONE 7(6):e38113. https:\/\/doi.org\/10.1371\/journal.pone.0038113","journal-title":"PLoS ONE"},{"key":"4115_CR105","doi-asserted-by":"publisher","unstructured":"Leng B, Sun H, Li M, Zhao J, Liu X, Yao R, ..., Zhang J (2022) Blood neuroexosomal excitatory amino acid transporter-2 is associated with cognitive decline in Parkinson\u2019s disease with RBD.\u00a0Front Aging Neurosci 14:952368. https:\/\/doi.org\/10.3389\/fnagi.2022.952368","DOI":"10.3389\/fnagi.2022.952368"},{"key":"4115_CR106","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/303294","volume":"2015","author":"S Sharma","year":"2015","unstructured":"Sharma S, Taliyan R (2015) Targeting histone deacetylases: a novel approach in Parkinson\u2019s disease. Parkinson\u2019s Dis 2015:303294. https:\/\/doi.org\/10.1155\/2015\/303294","journal-title":"Parkinson's Dis"},{"issue":"4","key":"4115_CR107","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1111\/cns.12217","volume":"20","author":"M Zhu","year":"2014","unstructured":"Zhu M, Li WW, Lu CZ (2014) Histone decacetylase inhibitors prevent mitochondrial fragmentation and elicit early neuroprotection against MPP+. CNS Neurosci Ther 20(4):308\u2013316. https:\/\/doi.org\/10.1111\/cns.12217","journal-title":"CNS Neurosci Ther"},{"key":"4115_CR108","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3389\/fphar.2020.00537","volume":"11","author":"S Shukla","year":"2020","unstructured":"Shukla S, Tekwani BL (2020) Histone deacetylases inhibitors in neurodegenerative diseases, neuroprotection and neuronal differentiation. Front Pharmacol 11:537. https:\/\/doi.org\/10.3389\/fphar.2020.00537","journal-title":"Front Pharmacol"},{"key":"4115_CR109","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3389\/fnana.2015.00010","volume":"9","author":"X d\u2019Anglemont de Tassigny","year":"2015","unstructured":"d\u2019Anglemont de Tassigny X, Pascual A, L\u00f3pez-Barneo J (2015) GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson\u2019s disease. Front Neuroanat 9:10. https:\/\/doi.org\/10.3389\/fnana.2015.00010","journal-title":"Front Neuroanat"},{"key":"4115_CR110","doi-asserted-by":"publisher","first-page":"372","DOI":"10.3389\/fnagi.2019.00372","volume":"11","author":"Y Liu","year":"2020","unstructured":"Liu Y, Zhang Y, Zhu K, Chi S, Wang C, Xie A (2020) Emerging role of Sirtuin 2 in Parkinson\u2019s disease. Front Aging Neurosci 11:372. https:\/\/doi.org\/10.3389\/fnagi.2019.00372","journal-title":"Front Aging Neurosci"},{"key":"4115_CR111","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.585821","volume":"11","author":"R Manjula","year":"2021","unstructured":"Manjula R, Anuja K, Alcain FJ (2021) SIRT1 and SIRT2 activity control in neurodegenerative diseases. Front Pharmacol 11:585821. https:\/\/doi.org\/10.3389\/fphar.2020.585821","journal-title":"Front Pharmacol"},{"key":"4115_CR112","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.785703","volume":"15","author":"H Komatsu","year":"2021","unstructured":"Komatsu H (2021) Innovative Therapeutic Approaches for Huntington\u2019s Disease: From Nucleic Acids to GPCR-Targeting Small Molecules. Front Cell Neurosci 15:785703. https:\/\/doi.org\/10.3389\/fncel.2021.785703","journal-title":"Front Cell Neurosci"},{"key":"4115_CR113","doi-asserted-by":"publisher","unstructured":"Daldin M, Fodale V, Cariulo C, Azzollini L, Verani M, Martufi P, ..., Caricasole A (2017) Polyglutamine expansion affects huntingtin conformation in multiple Huntington\u2019s disease models.\u00a0Sci Repo 7(1):1\u201315. https:\/\/doi.org\/10.1038\/s41598-017-05336-7","DOI":"10.1038\/s41598-017-05336-7"},{"issue":"2","key":"4115_CR114","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s13148-011-0025-7","volume":"2","author":"SG Gray","year":"2011","unstructured":"Gray SG (2011) Targeting Huntington\u2019s disease through histone deacetylases. Clin Epigenet 2(2):257\u2013277. https:\/\/doi.org\/10.1007\/s13148-011-0025-7","journal-title":"Clin Epigenet"},{"issue":"6","key":"4115_CR115","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253037","volume":"16","author":"M Seefelder","year":"2021","unstructured":"Seefelder M, Kochanek S (2021) A meta-analysis of transcriptomic profiles of Huntington\u2019s disease patients. PLoS ONE 16(6):e0253037. https:\/\/doi.org\/10.1371\/journal.pone.0253037","journal-title":"PLoS ONE"},{"issue":"2","key":"4115_CR116","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","volume":"9","author":"ME Ehrlich","year":"2012","unstructured":"Ehrlich ME (2012) Huntington\u2019s disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease. Neurotherapeutics 9(2):270\u2013284. https:\/\/doi.org\/10.1007\/s13311-012-0112-2","journal-title":"Neurotherapeutics"},{"key":"4115_CR117","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.nbd.2016.02.004","volume":"89","author":"D Guiretti","year":"2016","unstructured":"Guiretti D, Sempere A, Lopez-Atalaya JP, Ferrer-Montiel A, Barco A, Valor LM (2016) Specific promoter deacetylation of histone H3 is conserved across mouse models of Huntington\u2019s disease in the absence of bulk changes. Neurobiol Dis 89:190\u2013201. https:\/\/doi.org\/10.1016\/j.nbd.2016.02.004","journal-title":"Neurobiol Dis"},{"key":"4115_CR118","doi-asserted-by":"publisher","unstructured":"Le Gras S, Keime C, Anthony A, Lotz C, De Longprez L, Brouillet E, ..., Merienne K (2017) Altered enhancer transcription underlies Huntington\u2019s disease striatal transcriptional signature.\u00a0Sci Rep 7(1):42875. https:\/\/doi.org\/10.1038\/srep42875","DOI":"10.1038\/srep42875"},{"issue":"12","key":"4115_CR119","doi-asserted-by":"publisher","first-page":"4282","DOI":"10.3390\/ijms21124282","volume":"21","author":"B Lontay","year":"2020","unstructured":"Lontay B, Kiss A, Vir\u00e1g L, Tar K (2020) How do post-translational modifications influence the pathomechanistic landscape of Huntington\u2019s disease? A comprehensive review. Int J Mol Sci 21(12):4282. https:\/\/doi.org\/10.3390\/ijms21124282","journal-title":"Int J Mol Sci"},{"key":"4115_CR120","doi-asserted-by":"publisher","unstructured":"McFarland KN, Das S, Sun TT, Leyfer D, Xia E, Sangrey GR, ..., Cha JHJ (2012) Genome-wide histone acetylation is altered in a transgenic mouse model of Huntington's disease. https:\/\/doi.org\/10.1371\/journal.pone.0041423","DOI":"10.1371\/journal.pone.0041423"},{"issue":"1","key":"4115_CR121","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/JHD-159001","volume":"4","author":"KE Glajch","year":"2015","unstructured":"Glajch KE, Sadri-Vakili G (2015) Epigenetic mechanisms involved in Huntington\u2019s disease pathogenesis. J Huntington\u2019s Dis 4(1):1\u201315. https:\/\/doi.org\/10.3233\/JHD-159001","journal-title":"J Huntington's Dis"},{"issue":"3","key":"4115_CR122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0152498","volume":"11","author":"H Jia","year":"2016","unstructured":"Jia H, Wang Y, Morris CD, Jacques V, Gottesfeld JM, Rusche JR, Thomas EA (2016) The effects of pharmacological inhibition of histone deacetylase 3 (HDAC3) in Huntington\u2019s disease Mice. PLoS ONE 11(3):e0152498. https:\/\/doi.org\/10.1371\/journal.pone.0152498","journal-title":"PLoS ONE"},{"key":"4115_CR123","doi-asserted-by":"publisher","unstructured":"Schneider A, Chatterjee S, Bousiges O, Selvi BR, Swaminathan A, Cassel R, ..., Boutillier AL (2013) Acetyltransferases (HATs) as targets for neurological therapeutics.\u00a0Neurotherapeutics 10:568\u2013588. https:\/\/doi.org\/10.1007\/s13311-013-0204-7","DOI":"10.1007\/s13311-013-0204-7"},{"key":"4115_CR124","doi-asserted-by":"publisher","unstructured":"Mielcarek M, Landles C, Weiss A, Bradaia A, Seredenina T, Inuabasi L, ..., Bates GP (2013) HDAC4 reduction: a novel therapeutic strategy to target cytoplasmic huntingtin and ameliorate neurodegeneration.\u00a0PLoS Biol 11(11):e1001717. https:\/\/doi.org\/10.1371\/journal.pbio.1001717","DOI":"10.1371\/journal.pbio.1001717"},{"issue":"2","key":"4115_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031080","volume":"7","author":"L Moumn\u00e9","year":"2012","unstructured":"Moumn\u00e9 L, Campbell K, Howland D, Ouyang Y, Bates GP (2012) Genetic knock-down of HDAC3 does not modify disease-related phenotypes in a mouse model of Huntington\u2019s disease. PLoS ONE 7(2):e31080. https:\/\/doi.org\/10.1371\/journal.pone.0031080","journal-title":"PLoS ONE"},{"issue":"11","key":"4115_CR126","doi-asserted-by":"publisher","first-page":"22558","DOI":"10.3390\/ijms141122558","volume":"14","author":"EC Lauterbach","year":"2013","unstructured":"Lauterbach EC (2013) Neuroprotective effects of psychotropic drugs in Huntington\u2019s disease. Int J Mol Sci 14(11):22558\u201322603. https:\/\/doi.org\/10.3390\/ijms141122558","journal-title":"Int J Mol Sci"},{"key":"4115_CR127","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neuropharm.2015.07.015","volume":"99","author":"H Suo","year":"2015","unstructured":"Suo H, Wang P, Tong J, Cai L, Liu J, Huang D, Huang L, Wang Z, Huang Y, Xu J, Ma Y, Yu M, Fei J, Huang F (2015) NRSF is an essential mediator for the neuroprotection of trichostatin A in the MPTP mouse model of Parkinson\u2019s disease. Neuropharmacology 99:67\u201378. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.07.015","journal-title":"Neuropharmacology"},{"key":"4115_CR128","doi-asserted-by":"publisher","unstructured":"Wu X, Li S, Wu Q, Peng Y, Yu D, Wang H, ..., Zhao J (2013) Histone deacetylase inhibition leads to neuroprotection through regulation on glial function.\u00a0Mol Neurodegener 8(1):1\u20132. https:\/\/doi.org\/10.1186\/1750-1326-8-s1-p49","DOI":"10.1186\/1750-1326-8-s1-p49"},{"issue":"20","key":"4115_CR129","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","volume":"15","author":"E Kontopoulos","year":"2006","unstructured":"Kontopoulos E, Parvin JD, Feany MB (2006) \u03b1-Synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity. Hum Mol Genet 15(20):3012\u20133023. https:\/\/doi.org\/10.1093\/hmg\/ddl243","journal-title":"Hum Mol Genet"},{"key":"4115_CR130","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","volume":"246","author":"R St Laurent","year":"2013","unstructured":"St Laurent R, O\u2019Brien LM, Ahmad ST (2013) Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson\u2019s disease. Neuroscience 246:382\u2013390. https:\/\/doi.org\/10.1016\/j.neuroscience.2013.04.037","journal-title":"Neuroscience"},{"key":"4115_CR131","doi-asserted-by":"publisher","unstructured":"Ximenes JCM, Neves KRT, Leal LKA, do Carmo MRS, Brito GADC, Naffah-Mazzacoratti MDG, ..., Viana GSDB (2015) Valproic acid neuroprotection in the 6-OHDA model of Parkinson\u2019s disease is possibly related to its anti-inflammatory and HDAC inhibitory properties.\u00a0J Neurodegener Dis 2015. https:\/\/doi.org\/10.1155\/2015\/313702","DOI":"10.1155\/2015\/313702"},{"key":"4115_CR132","doi-asserted-by":"publisher","unstructured":"Zhang C, Yuan X, Hu Z, Liu S, Li H, Wu M, ..., Liu Q (2017) Valproic acid protects primary dopamine neurons from MPP+-Induced neurotoxicity: involvement of GSK3\u03b2 phosphorylation by Akt and ERK through the mitochondrial intrinsic apoptotic pathway.\u00a0BioMed Res Int 2017. https:\/\/doi.org\/10.1155\/2017\/8124501","DOI":"10.1155\/2017\/8124501"},{"issue":"08","key":"4115_CR133","first-page":"1086","volume":"123","author":"HR Xie","year":"2010","unstructured":"Xie HR, Hu LS, Li GY (2010) SH-SY5Y human neuroblastoma cell line: in vitro cell model of dopaminergic neurons in Parkinson\u2019s disease. Chin Med J 123(08):1086\u20131092","journal-title":"Chin Med J"},{"issue":"13","key":"4115_CR134","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1093\/emboj\/cdg315","volume":"22","author":"OH Kr\u00e4mer","year":"2003","unstructured":"Kr\u00e4mer OH, Zhu P, Ostendorff HP, Golebiewski M, Tiefenbach J, Peters MA, Brill B, Groner B et al (2003) The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 22(13):3411\u20133420. https:\/\/doi.org\/10.1093\/emboj\/cdg315","journal-title":"EMBO J"},{"issue":"2","key":"4115_CR135","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong YC, Krainc D (2017) \u03b1-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies. Nat Med 23(2):1\u201313. https:\/\/doi.org\/10.1038\/nm.4269","journal-title":"Nat Med"},{"key":"4115_CR136","doi-asserted-by":"crossref","unstructured":"Li Y, Gu Z, Lin S, Chen L, Dzreyan V, Eid M, ..., He B (2022) Histone deacetylases as epigenetic targets for treating Parkinson\u2019s disease.\u00a0Brain Sci 12(5):672.","DOI":"10.3390\/brainsci12050672"},{"key":"4115_CR137","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.neulet.2017.12.037","volume":"666","author":"IF Harrison","year":"2018","unstructured":"Harrison IF, Smith AD, Dexter DT (2018) Pathological histone acetylation in Parkinson\u2019s disease: neuroprotection and inhibition of microglial activation through SIRT 2 inhibition. Neurosci Lett 666:48\u201357. https:\/\/doi.org\/10.1016\/j.neulet.2017.12.037","journal-title":"Neurosci Lett"},{"key":"4115_CR138","doi-asserted-by":"publisher","unstructured":"Khan N, Jeffers M, Kumar S, Hackett C, Boldog F, Khramtsov N, ..., Sehested M (2008)\u00a0 Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors.\u00a0Biochem J 409(2):581\u2013589. https:\/\/doi.org\/10.1042\/BJ20070779","DOI":"10.1042\/BJ20070779"},{"issue":"1","key":"4115_CR139","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13195-020-00746-8","volume":"13","author":"Q Su","year":"2021","unstructured":"Su Q, Li T, He PF, Lu XC, Yu Q, Gao QC, Wang ZJ, Wu MN, Yang D, Qi JS (2021) Trichostatin A ameliorates Alzheimer\u2019s disease-related pathology and cognitive deficits by increasing albumin expression and A\u03b2 clearance in APP\/PS1 mice. Alzheimer\u2019s Res Ther 13(1):7. https:\/\/doi.org\/10.1186\/s13195-020-00746-8","journal-title":"Alzheimer's Res Ther"},{"issue":"4","key":"4115_CR140","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/bja\/aeu184","volume":"113","author":"T Zhong","year":"2014","unstructured":"Zhong T, Qing QJ, Yang Y, Zou WY, Ye Z, Yan JQ, Guo QL (2014) Repression of contexual fear memory induced by isoflurane is accompanied by reduction in histone acetylation and rescued by sodium butyrate. Br J Anaesth 113(4):634\u2013643. https:\/\/doi.org\/10.1093\/bja\/aeu184","journal-title":"Br J Anaesth"},{"issue":"12","key":"4115_CR141","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1084\/jem.20081588","volume":"205","author":"H Qing","year":"2008","unstructured":"Qing H, He G, Ly PT, Fox CJ, Staufenbiel M, Cai F, Zhang Z, Wei S et al (2008) Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer\u2019s disease mouse models. J Exp Med 205(12):2781\u20132789. https:\/\/doi.org\/10.1084\/jem.20081588","journal-title":"J Exp Med"},{"issue":"6","key":"4115_CR142","doi-asserted-by":"publisher","first-page":"5267","DOI":"10.1523\/JNEUROSCI.5478-10.2011","volume":"14","author":"Y Sun","year":"2017","unstructured":"Sun Y, Zhang JR, Chen S (2017) Suppression of Alzheimer\u2019s disease-related phenotypes by the heat shock protein 70 inducer, geranylgeranylacetone, in APP\/PS1 transgenic mice via the ERK\/p38 MAPK signaling pathway. Exp Ther Med 14(6):5267\u20135274. https:\/\/doi.org\/10.1523\/JNEUROSCI.5478-10.2011","journal-title":"Exp Ther Med"},{"issue":"1","key":"4115_CR143","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1021\/ml1001954","volume":"2","author":"DM Fass","year":"2010","unstructured":"Fass DM, Shah R, Ghosh B, Hennig K, Norton S, Zhao WN, Reis SA, Klein PS, Mazitschek R, Maglathlin RL, Lewis TA, Haggarty SJ (2010) Effect of inhibiting histone deacetylase with short-chain carboxylic acids and their hydroxamic acid analogs on vertebrate development and neuronal chromatin. ACS Med Chem Lett 2(1):39\u201342. https:\/\/doi.org\/10.1021\/ml1001954","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"4115_CR144","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3233\/JAD-2009-1134","volume":"18","author":"YI Francis","year":"2009","unstructured":"Francis YI, F\u00e0 M, Ashraf H, Zhang H, Staniszewski A, Latchman DS, Arancio O (2009) Dysregulation of histone acetylation in the APP\/PS1 mouse model of Alzheimer\u2019s disease. J Alzheimer\u2019s Dis 18(1):131\u2013139. https:\/\/doi.org\/10.3233\/JAD-2009-1134","journal-title":"J Alzheimer's Dis"},{"key":"4115_CR145","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13148-015-0142-9","volume":"7","author":"M Cuadrado-Tejedor","year":"2015","unstructured":"Cuadrado-Tejedor M, Garcia-Barroso C, Sanzhez-Arias J, Mederos S, Rabal O, Ugarte A, Franco R, Pascual-Lucas M et al (2015) Concomitant histone deacetylase and phosphodiesterase 5 inhibition synergistically prevents the disruption in synaptic plasticity and it reverses cognitive impairment in a mouse model of Alzheimer\u2019s disease. Clin Epigenet 7:108. https:\/\/doi.org\/10.1186\/s13148-015-0142-9","journal-title":"Clin Epigenet"},{"issue":"28","key":"4115_CR146","doi-asserted-by":"publisher","first-page":"5076","DOI":"10.2174\/1381612811319280006","volume":"19","author":"M Cuadrado-Tejedor","year":"2013","unstructured":"Cuadrado-Tejedor M, Ricobaraza AL, Torrijo R, Franco R, Garcia-Osta A (2013) Phenylbutyrate is a multifaceted drug that exerts neuroprotective effects and reverses the Alzheimer\u00b4s disease-like phenotype of a commonly used mouse model. Curr Pharm Des 19(28):5076\u20135084. https:\/\/doi.org\/10.2174\/1381612811319280006","journal-title":"Curr Pharm Des"},{"key":"4115_CR147","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1007\/s12035-016-9951-x","volume":"54","author":"DF Silva","year":"2017","unstructured":"Silva DF, Esteves AR, Oliveira CR, Cardoso SM (2017) Mitochondrial metabolism power SIRT2-dependent deficient traffic causing Alzheimer\u2019s-disease related pathology. Mol Neurobiol 54:4021\u20134040. https:\/\/doi.org\/10.1007\/s12035-016-9951-x","journal-title":"Mol Neurobiol"},{"issue":"45","key":"4115_CR148","doi-asserted-by":"publisher","first-page":"11500","DOI":"10.1523\/JNEUROSCI.3203-08.2008","volume":"28","author":"KN Green","year":"2008","unstructured":"Green KN, Steffan JS, Martinez-Coria H, Sun X, Schreiber SS, Thompson LM, LaFerla FM (2008) Nicotinamide restores cognition in Alzheimer\u2019s disease transgenic mice via a mechanism involving sirtuin inhibition and selective reduction of Thr231-phosphotau. J Neurosci 28(45):11500\u201311510. https:\/\/doi.org\/10.1523\/JNEUROSCI.3203-08.2008","journal-title":"J Neurosci"},{"issue":"3","key":"4115_CR149","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1007\/s13311-013-0195-4","volume":"10","author":"B Calamini","year":"2013","unstructured":"Calamini B, Lo DC, Kaltenbach LS (2013) Experimental models for identifying modifiers of polyglutamine-induced aggregation and neurodegeneration. Neurotherapeutics 10(3):400\u2013415. https:\/\/doi.org\/10.1007\/s13311-013-0195-4","journal-title":"Neurotherapeutics"},{"issue":"13","key":"4115_CR150","doi-asserted-by":"publisher","first-page":"3571","DOI":"10.1523\/JNEUROSCI.0037-07.2007","volume":"27","author":"JP Dompierre","year":"2007","unstructured":"Dompierre JP, Godin JD, Charrin BC, Cordelieres FP, King SJ, Humbert S, Saudou F (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington\u2019s disease by increasing tubulin acetylation. J Neurosci 27(13):3571\u20133583. https:\/\/doi.org\/10.1523\/JNEUROSCI.0037-07.2007","journal-title":"J Neurosci"},{"issue":"28","key":"4115_CR151","doi-asserted-by":"publisher","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","volume":"23","author":"RJ Ferrante","year":"2003","unstructured":"Ferrante RJ, Kubilus JK, Lee J, Ryu H, Beesen A, Zucker B, Smith K, Kowall NW, Ratan RR, Luthi-Carter R, Hersch SM (2003) Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington\u2019s disease mice. J Neurosci 23(28):9418\u20139427. https:\/\/doi.org\/10.1523\/JNEUROSCI.23-28-09418.2003","journal-title":"J Neurosci"},{"issue":"12","key":"4115_CR152","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1038\/npp.2011.128","volume":"36","author":"CT Chiu","year":"2011","unstructured":"Chiu CT, Liu G, Leeds P, Chuang DM (2011) Combined treatment with the mood stabilizers lithium and valproate produces multiple beneficial effects in transgenic mouse models of Huntington\u2019s disease. Neuropsychopharmacology 36(12):2406\u20132421. https:\/\/doi.org\/10.1038\/npp.2011.128","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"4115_CR153","first-page":"10","volume":"8","author":"M Mukhi","year":"2020","unstructured":"Mukhi M, Jai J (2020) Evaluating the potency of three plant compounds as HDAC Inhibitors for the treatment of Huntington\u2019s disease: an in silico study. Int J Herb Med 8(5):10\u201313","journal-title":"Int J Herb Med"},{"issue":"11","key":"4115_CR154","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0027746","volume":"6","author":"M Mielcarek","year":"2011","unstructured":"Mielcarek M, Benn CL, Franklin SA, Smith DL, Woodman B, Marks PA, Bates GP (2011) SAHA decreases HDAC 2 and 4 levels in vivo and improves molecular phenotypes in the R6\/2 mouse model of Huntington\u2019s disease. PLoS ONE 6(11):e27746. https:\/\/doi.org\/10.1371\/journal.pone.0027746","journal-title":"PLoS ONE"},{"key":"4115_CR155","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3389\/fneur.2013.00127","volume":"4","author":"L Moumn\u00e9","year":"2013","unstructured":"Moumn\u00e9 L, Betuing S, Caboche J (2013) Multiple aspects of gene dysregulation in Huntington\u2019s disease. Front Neurol 4:127. https:\/\/doi.org\/10.3389\/fneur.2013.00127","journal-title":"Front Neurol"},{"key":"4115_CR156","doi-asserted-by":"publisher","unstructured":"Benn CL, Butler R, Mariner L, Nixon J, Moffitt H, Mielcarek M, ..., Bates GP (2009) Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6\/2 mouse model of Huntington's disease.\u00a0PLoS One 4(6):e5747. https:\/\/doi.org\/10.1371\/journal.pone.0005747","DOI":"10.1371\/journal.pone.0005747"},{"key":"4115_CR157","doi-asserted-by":"publisher","unstructured":"Chopra V, Quinti L, Kim J, Vollor L, Narayanan KL, Edgerly C, ..., Kazantsev AG (2012) The sirtuin 2 inhibitor AK-7 is neuroprotective in Huntington\u2019s disease mouse models.\u00a0Cell Rep 2(6):1492\u20131497. https:\/\/doi.org\/10.1016\/j.celrep.2012.11.001","DOI":"10.1016\/j.celrep.2012.11.001"},{"issue":"5","key":"4115_CR158","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40263-013-0055-0","volume":"27","author":"W Duan","year":"2013","unstructured":"Duan W (2013) Targeting sirtuin-1 in Huntington\u2019s disease: rationale and current status. CNS Drugs 27(5):345\u2013352. https:\/\/doi.org\/10.1007\/s40263-013-0055-0","journal-title":"CNS Drugs"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04115-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-024-04115-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-024-04115-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T11:04:15Z","timestamp":1729595055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-024-04115-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,8]]},"references-count":158,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["4115"],"URL":"https:\/\/doi.org\/10.1007\/s12035-024-04115-6","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,8]]},"assertion":[{"value":"29 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}